Loading...
XNASTCMD
Market cap415mUSD
Dec 24, Last price  
17.33USD
1D
2.79%
1Q
24.68%
Jan 2017
5.61%
IPO
53.91%
Name

Tactile Systems Technology Inc

Chart & Performance

D1W1MN
XNAS:TCMD chart
P/E
14.58
P/S
1.52
EPS
1.19
Div Yield, %
0.00%
Shrs. gr., 5y
3.68%
Rev. gr., 5y
13.81%
Revenues
274m
+11.20%
37,176,00047,736,00062,872,00084,542,000109,283,000143,751,000189,492,000187,130,000208,057,000246,785,000274,423,000
Net income
29m
P
3,156,0002,070,0001,393,0002,879,0005,855,0006,623,00010,971,000-620,000-11,811,000-17,866,00028,515,000
CFO
36m
+588.33%
-11,811,000-425,000-991,0001,358,0007,033,0004,192,0009,007,0002,510,0002,794,0002,631,0005,209,00035,855,000
Earnings
Feb 18, 2025

Profile

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
URL
https://www.tactilemedical.com/
IPO date
Jul 28, 2016
Employees
982
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
274,423
11.20%
246,785
18.61%
208,057
11.18%
Cost of revenue
256,306
245,111
209,080
Unusual Expense (Income)
NOPBT
18,117
1,674
(1,023)
NOPBT Margin
6.60%
0.68%
Operating Taxes
(12,745)
2,393
9,518
Tax Rate
142.95%
NOPAT
30,862
(719)
(10,541)
Net income
28,515
-259.60%
(17,866)
51.27%
(11,811)
1,805.00%
Dividends
Dividend yield
Proceeds from repurchase of equity
34,625
2,725
5,115
BB yield
-10.45%
-1.18%
-1.36%
Debt
Debt current
5,763
5,468
8,716
Long-term debt
65,855
90,127
101,004
Deferred revenue
3,456
Other long-term liabilities
2,127
2,505
2,950
Net debt
10,285
34,175
69,041
Cash flow
Cash from operating activities
35,855
5,209
2,631
CAPEX
(2,324)
(1,920)
(2,355)
Cash from investing activities
(2,481)
(1,909)
(82,184)
Cash from financing activities
5,730
(9,600)
59,927
FCF
5,163
26,865
(20,935)
Balance
Cash
61,033
38,059
40,711
Long term investments
300
23,361
(32)
Excess cash
47,612
49,081
30,276
Stockholders' equity
18,918
(9,601)
8,265
Invested Capital
227,226
203,399
210,212
ROIC
14.33%
ROCE
7.36%
0.86%
EV
Common stock shares outstanding
23,176
20,068
19,719
Price
14.30
24.56%
11.48
-39.67%
19.03
-57.65%
Market cap
331,419
43.86%
230,380
-38.61%
375,262
-56.84%
EV
341,704
264,555
444,303
EBITDA
24,656
7,942
2,658
EV/EBITDA
13.86
33.31
167.16
Interest
10,879
Interest/NOPBT
649.88%